$324 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 63 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 46.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HZNP | Sell | HORIZON THERAPEUTICS PLC | $35,828,179 | +27.2% | 314,973 | -30.8% | 11.06% | +22.5% |
INCY | Sell | INCYTE CORP INC COM | $18,390,990 | -4.5% | 229,000 | -20.8% | 5.68% | -8.0% |
BIIB | Sell | BIOGEN INC COMMON STOCK | $5,923,520 | -51.2% | 21,400 | -53.0% | 1.83% | -53.1% |
GILD | Sell | GILEAD SCIENCES INC COMMO | $4,942,435 | -61.6% | 57,584 | -72.4% | 1.53% | -63.1% |
BMRN | Sell | BIOMARIN PHARMACEUTICAL I | $4,514,467 | -9.2% | 43,656 | -25.6% | 1.39% | -12.5% |
IMAB | Sell | I-MAB SPONSORED ADSsponsored ads | $1,291,676 | -36.2% | 310,499 | -38.8% | 0.40% | -38.5% |
FATE | Sell | FATE THERAPEUTICS INC COM | $463,680 | -82.9% | 46,000 | -62.0% | 0.14% | -83.6% |
MDGL | Exit | MADRIGAL PHARMS. | $0 | – | -5,350 | -100.0% | -0.11% | – |
AXSM | Exit | AXSOME THERAPEUTICS | $0 | – | -14,000 | -100.0% | -0.20% | – |
VTRS | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -364,000 | -100.0% | -0.99% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES | $0 | – | -30,000 | -100.0% | -1.02% | – |
KALV | Exit | KALVISTA PHARMS. | $0 | – | -316,133 | -100.0% | -1.47% | – |
GLPG | Exit | GALAPAGOS NVsponsored adr | $0 | – | -123,300 | -100.0% | -1.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-01
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
AMGEN INC COM | 25 | Q3 2023 | 7.9% |
NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-18 |
13F-HR | 2023-02-01 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-20 |
13F-HR | 2022-02-15 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.